Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 9, 2022
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
[ Tue, Aug 09th 2022
] - WOPRAI
Larry Biegelsen Downgraded (TNDM) to Sell and Decreased Target to $49 on, Aug 9th, 2022
Larry Biegelsen of Wells Fargo, Downgraded "Tandem Diabetes Care, Inc." (TNDM) to Sell and Decreased Target from $82 to $49 on, Aug 9th, 2022.
Larry has made no other calls on TNDM in the last 4 months.
There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 1 agrees with Larry's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $110 on, Thursday, May 5th, 2022
These are the ratings of the 4 analyists that currently disagree with Larry
- Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Thursday, August 4th, 2022
- Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $82 on, Thursday, August 4th, 2022
- Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $80 on, Thursday, August 4th, 2022
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $130 on, Tuesday, May 17th, 2022
